17 results on '"Raab, Rachel"'
Search Results
2. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update
3. In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
4. Patient Navigation and the Quality of Breast Cancer Care: An Analysis of the Breast Cancer Care Quality Indicators
5. Increasing the tamoxifen dose in CYP2D6 intermediate metabolizers increases toxicity.: 167E.
6. Implementing a personalized medicine cancer program in a community cancer system
7. In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
8. Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity
9. Neoadjuvant metronomic chemotherapy in triple-negative breast cancer (TNBC) (NCT00542191): Updated results from a phase II trial.
10. In vivoassessment of the metabolic activity of CYP2D6 diplotypes and alleles
11. Abstract P1-03-02: CYP2D6 intermediate metabolizers includes patient groups with distinct metabolic activity
12. Does increasing the daily tamoxifen dose in patients with diminished CYP2D6 activity increase toxicity?
13. Insurance status as a strong predictor of outcome in triple-negative breast cancer (TNBC): A multi-institutional retrospective study.
14. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer
15. Results of the East Carolina Breast Center phase II trial of neoadjuvant metronomic chemotherapy in triple-negative breast cancer (NCT00542191).
16. Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
17. A Phase I Trial of Oblimersen Sodium in Combination With Cisplatin and 5-Fluorouracil in Patients With Advanced Esophageal, Gastroesophageal Junction, and Gastric Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.